What is the Gujarat Themis Biosyn Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 3.80% of the total equity shares of Gujarat Themis Biosyn Ltd.

What is the Gujarat Themis Biosyn Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 12.65% of the total equity shares of Gujarat Themis Biosyn Ltd.

How has the Gujarat Themis Biosyn Ltd promoter holding changed?

The promoter holding in Gujarat Themis Biosyn Ltd changed from 59.33% to 59.33% during the latest reported period.

How has the Gujarat Themis Biosyn Ltd FII holding changed?

The FII holding in Gujarat Themis Biosyn Ltd changed from 4.93% to 3.80% during the latest reported period.

How has the Gujarat Themis Biosyn Ltd DII holding changed?

The DII holding in Gujarat Themis Biosyn Ltd changed from 13.79% to 12.65% during the latest reported period.

Who are the major shareholders of Gujarat Themis Biosyn Ltd?

The major shareholders of Gujarat Themis Biosyn Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Gujarat Themis Biosyn Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Gujarat Themis Biosyn Ltd public shareholding?

Public shareholders hold 24.22% of the total equity shares of Gujarat Themis Biosyn Ltd as per the latest available data.

Gujarat Themis Biosyn Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk DrugsNSE

₹324.00

-29.40(-8.32%)

As on 23 Oct 2026 at 15:54

As of 23 Oct 2026 at 15:54, Gujarat Themis Biosyn Ltd is trading at ₹324.00. The 52-week range stands at ₹225.05–₹479.00, with a market cap of ₹4.26 thousand crore. At a P/E of 87.50 and a dividend yield of 0.17%, it is a small-cap stock in the Pharmaceuticals sector.